SYNTOPIX GROUP

Syntopix Group plc is a drug development company focused on prescription and over-the counter products for the treatment of common inflammatory skin conditions. Our vision is to become a world-class company providing clinical solutions for important dermatological diseases. This will be achieved by creating a continuous pipeline of novel products for the topical treatment and prevention of dermatological conditions, principally acne and staphylococcal infections including MRSA. The Syntopix s... trategy has been designed to reduce the risks and costs associated with drug discovery and development. We concentrate on change of use and combinations of known compounds with well-documented pharmacology and toxicity profiles that are already established as safe for human use. This allows a more efficient route through discovery, pre-clinical and clinical development and increases the probability of success.More